• 제목/요약/키워드: Genetic Testing

검색결과 445건 처리시간 0.027초

Association between Histone Deacetylase 9 Gene Polymorphism and Stroke in Chinese Han Population

  • Yang, Xitong;Xu, Hongyang;Liu, Dan;Ma, Rong;Zhang, Yuanyuan;Wang, Guangming
    • Journal of Korean Neurosurgical Society
    • /
    • 제64권2호
    • /
    • pp.309-315
    • /
    • 2021
  • Objective : To explore the correlation between the polymorphism of histone deacetylase 9 gene (rs1060499865, rs723296, rs957960) and ischemic stroke (IS) in Chinese Han population in Dali region. Methods : This study included 155 IS patients and 128 healthy physical examinees. TaqMan-polymerase chain reaction technology and multivariate logistic regression were performed. Results : In the case group, there was no polymorphism of rs1060499865 observed in the two groups; whereas on the rs723296 locus the frequencies of C allele and TC genotype were significantly higher than that in the control group, alleles C and T were associated with a 2.158-fold increase in IS risk, and genotypes TC and TT were associated with a 2.269-fold increase in IS risk. The locus rs957960 exhibited no significant difference between the two groups. Conclusion : An association between rs723296 and the risk of IS was found in the Chinese Han population in Dali region. No significant association was found between rs1060499865, rs957960 and IS in the Chinese Han population in Dali region.

Clinical Application of Chromosomal Microarray for Germline Disorders

  • Chang Ahn Seol
    • Journal of Interdisciplinary Genomics
    • /
    • 제5권2호
    • /
    • pp.24-28
    • /
    • 2023
  • Chromosomal microarray (CMA) is primarily recommended for detecting clinically significant copy number variants (CNVs) in the genetic diagnosis of developmental delay, intellectual disability, autism, and congenital malformations. Prenatal CMA is recommended when a fetus has major congenital malformations. The main principles of CMA can be divided into array comparative genomic hybridization and single-nucleotide polymorphism arrays. In the current CMA platforms, these two principles are combined, and detection of genetic abnormalities including CNVs and absence of heterozygosity is facilitated. In this review, I described practical assessment of CMA testing regarding to laboratory management of CMA, interpretation of CNVs, and special considerations for comprehensive genetic counseling.

Performance Comparison between Neural Network and Genetic Programming Using Gas Furnace Data

  • Bae, Hyeon;Jeon, Tae-Ryong;Kim, Sung-Shin
    • Journal of information and communication convergence engineering
    • /
    • 제6권4호
    • /
    • pp.448-453
    • /
    • 2008
  • This study describes design and development techniques of estimation models for process modeling. One case study is undertaken to design a model using standard gas furnace data. Neural networks (NN) and genetic programming (GP) are each employed to model the crucial relationships between input factors and output responses. In the case study, two models were generated by using 70% training data and evaluated by using 30% testing data for genetic programming and neural network modeling. The model performance was compared by using RMSE values, which were calculated based on the model outputs. The average RMSE for training and testing were 0.8925 (training) and 0.9951 (testing) for the NN model, and 0.707227 (training) and 0.673150 (testing) for the GP model, respectively. As concern the results, the NN model has a strong advantage in model training (using the all data for training), and the GP model appears to have an advantage in model testing (using the separated data for training and testing). The performance reproducibility of the GP model is good, so this approach appears suitable for modeling physical fabrication processes.

Test Set Generation for Pairwise Testing Using Genetic Algorithms

  • Sabharwal, Sangeeta;Aggarwal, Manuj
    • Journal of Information Processing Systems
    • /
    • 제13권5호
    • /
    • pp.1089-1102
    • /
    • 2017
  • In software systems, it has been observed that a fault is often caused by an interaction between a small number of input parameters. Even for moderately sized software systems, exhaustive testing is practically impossible to achieve. This is either due to time or cost constraints. Combinatorial (t-way) testing provides a technique to select a subset of exhaustive test cases covering all of the t-way interactions, without much of a loss to the fault detection capability. In this paper, an approach is proposed to generate 2-way (pairwise) test sets using genetic algorithms. The performance of the algorithm is improved by creating an initial solution using the overlap coefficient (a similarity matrix). Two mutation strategies have also been modified to improve their efficiency. Furthermore, the mutation operator is improved by using a combination of three mutation strategies. A comparative survey of the techniques to generate t-way test sets using genetic algorithms was also conducted. It has been shown experimentally that the proposed approach generates faster results by achieving higher percentage coverage in a fewer number of generations. Additionally, the size of the mixed covering arrays was reduced in one of the six benchmark problems examined.

The Genetic Development of Sire, Dam and Progenies and Genotype ${\times}$ Environment Interaction in a Beef Breeding System

  • Bhuiyan, A.K.F.H.;Dietl, G.;Klautschek, G.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제17권1호
    • /
    • pp.13-17
    • /
    • 2004
  • The aim of this study was to investigate genetic development and genotype${\times}$environment interactions (GEI) in postweaning body weight of fattening bulls at the end of test period (WT-T) under various beef fattening environments. Data on a total of 24,247 fattening bulls obtained from the industrial farm, breeding farms and testing stations were used. Heritability estimates for WT-T in all environments were nearly similar. Significant genetic developments of sire, dam and progenies for WT-T were observed in all environments. However, many differences in annual genetic developments between the environments were significant. The genetic correlations for WT-T between industrial farm and breeding farms, industrial farm and testing stations and breeding farms and testing stations were respectively 0.004, 0.004 and 0.013. These low estimates of genetic correlations and significant differences in genetic developments among environments clearly show the existence of GEI for WT-T among various fattening environments. Results of this study indicate the need for environment-specific genetic evaluation and selection of beef bulls for commercial beef production.

Saudi Women's Interest in Breast Cancer Gene Testing: Possible Influence of Awareness, Perceived Risk and Socio-demographic Factors

  • Amin, Tarek Tawfik;Al-Wadaani, Hamed Abdullah;Al-Quaimi, Manal Mubarak;Aldairi, Nedaa' Abdullah;Alkhateeb, Jawaher Mohammed;Al-Jaafari, Azzam Abdul Lateef
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권8호
    • /
    • pp.3879-3887
    • /
    • 2012
  • Background: Development of effective educational strategies should accompany increases in public awareness and the availability of genetic testing for breast cancer (BC). These educational strategies should be designed to fulfill the knowledge gap while considering factors that influence women's interest in order to facilitate decision making. Objective: To determine the possible correlates of Saudi women's interest in BC genes testing including socio-demographics, the level of awareness towards BC genes, the family history of BC and the perceived personal risk among adult Saudi women in Al Hassa, Saudi Arabia. Subjects and methods: This cross-sectional study was carried out during the second BC community-based campaign in Al Hassa, Saudi Arabia. All Saudi women aged ${\geq}18$ years (n=781) attending the educational components of the campaign were invited to a personal interview. Data collection included gathering information about sociodemographics, family history of BC, the perceived personal risk for BC, awareness and attitude towards BC genes and the women's interest in BC genes testing. Results: Of the included women (n=599), 19.5% perceived higher risk for BC development, significantly more among < 40 years of age, and with positive family history of BC before 50 years of age. The participants demonstrated a poor level of awareness regarding the inheritance, risk, and availability of BC genetic testing. The median summated knowledge score was 1.0 (out of 7 points) with a knowledge deficit of 87.8%. The level of knowledge showed significant decline with age (> 40 years). Of the included women 54.7% expressed an interest in BC genetic testing for assessing their BC risk. Multivariate regression model showed that being middle aged (Odds Ratio 'OR'=1.88, confidence intervals 'C.I'=1.14-3.11), with higher knowledge level (OR=1.67, C.I=1.08-2.57) and perceiving higher risk for BC (OR=2.11, C.I=1.61-2.76) were the significant positive correlates for Saudi women interest in BC genetic testing. Conclusion: Saudi women express high interest in genetic testing for BC risk despite their poor awareness. This great interest may reflect the presence of inappropriate information regarding BC genetic testing and its role in risk analysis.

산전검사 대상 질환에 대한 법적 규제의 문제점에 대한 고찰 (Controversial issues in the legal restriction for prenatal genetic testing in Korea)

  • 최지영;정선용;김현주
    • Journal of Genetic Medicine
    • /
    • 제4권2호
    • /
    • pp.186-189
    • /
    • 2007
  • 현재까지 보고 된 유전질환을 포함한 희귀질환은 6000종이 넘으며, 이 중 2007년 12월 현재, 1,500종(임상검사 목적 1,211종과 연구 목적 289)의 유전자 검사가 가능하다. 외국의 경우, 원인 유전자가 밝혀지고 진단이 가능한 모든 유전질환에 대해 착상 전 및 산전 유전자검사가 가능한데 반해, 국내에서는 2005년 제정된 생명윤리 및 안전에 관한 법률 제25조 2항에 의해 착상전 및 산전 유전자검사가 가능한 유전 질환은 63종으로 제한되어 있다. 이 보고에서는, 63종으로 제한된 검사항목에 포함되어 있지 않아 산전 진단을 할 수 없게 된 최근의 증례를 검토하고 문제점과 대안에 대해 논의하였다. X-성염색체 연관 열성질환인 MNK의 보인자로 확진된 L씨(여 38세)는 2명의 자녀를 출산하였는데, 그중 1명은 MNK에 이환된 남아로 출생 후 사망하였다. L씨는 2003년에 산전 유전자검사를 실시하여 정상의 남아를 출산하였다. 현재 임신 중인 L씨는 MNK에 이환된 남아를 또다시 출산할 가능성이 50%로 산전 유전자 검사가 필요하지만, 2005년에 제정된 생명윤리 및 안전에 관한 법률에 의해 산전 유전자검사가 법적으로 불가능하였다. 이 증례는 유전질환 검사항목을 63종으로 제한한 현행법의 문제점과 질환 형평성의 문제점을 실질적으로 보여주고 있다. 질환 명에 상관없이 유전질환의 가족력이 있는 가족에게는 산전 유전자검사에 대한 자기결정의 기회가 제공되어야 할 것이며, 만일, 현행법의 개정이 현실적으로 불가능하다면, MNK처럼 3년 내에 사망에 이르는 등 질병의 정도가 심하며, 효과적인 치료 방법이 없는 질환에 대해서는 산모나 가족이 원하는 경우 전문의의 전문적인 판단에 근거하여 예외가 인정되어야 한다고 사료된다.

  • PDF

윌슨병의 진단과 분자유전학적 검사 (Molecular Genetic Testing and Diagnosis of Wilson Disease)

  • 서정기
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제11권sup1호
    • /
    • pp.72-82
    • /
    • 2008
  • Wilson disease (WD) is an autosomal recessive disorder of copper metabolism that results in accumulation of copper primarily in the liver, the brain and the cornea. Mutations in the WD gene, ATP7B cause failure of copper excretion from hepatocyte into bile and a defective synthesis of ceruloplasmin. More than 370 mutations are now recognized, scattering throughout the ATP7B gene. Since WD has protean clinical presentations, awareness of WD in clinical practice is important for the early diagnosis and prevention of accumulated copper toxicity. None of the laboratory parameters alone allows a definite diagnosis of WD. There are numerous pitfalls in the diagnosis of WD. Low serum ceruloplasmin concentrations, increased 24 hour urinary copper excretion, increased hepatic copper concentrations and the presence of Kayser-Fleischer rings in the cornea are major diagnostic points. A combination of any two of these 4 laboratory findings is strong support for a diagnosis of WD. Molecular methods are now being used to aid diagnosis. Molecular genetic testing has confirmed the diagnosis in individuals in whom the diagnosis is not clearly established biochemically and clinically. Siblings should be screened for WD once an index case has been diagnosed. Discrimination of heterozygotes from asymptomatic patients is essential to avoid inappropriate lifelong therapy for heterozygotes. Genetic testing, either by haplotype analysis or by mutation analysis, is the only reliable tool for differentiating heterozygote carriers from affected asymptomatic patients. Currently, genetic testing is of limited value in the primary diagnosis. However, genetic testing will soon play an essential role in diagnosing WD as rapid advancement of biomedical technology will allow more rapid, easier and less expensive mutation detection.

  • PDF

유전자 알고리즘을 이용한 뮤테이션 테스팅의 테스트 데이터 자동 생성 (Automatic Test Data Generation for Mutation Testing Using Genetic Algorithms)

  • 정인상;창병모
    • 정보처리학회논문지D
    • /
    • 제8D권1호
    • /
    • pp.81-86
    • /
    • 2001
  • 소프트웨어 테스팅의 중요 목표 중의 하나는 '좋은' 테스트 데이터 집합을 생성하는 것으로 이는 매우 어렵고 시간이 걸리는 작업이다. 본 논문은 소프트웨어 테스팅을 위한 자동 테스트 데이터 집합 생성에 유전자 알고리즘을 적용하는 방법을 제시하며 자동 테스트 데이터 생성에서 유전자 알고리즘의 효용성을 보이기 위해 유테이션 테스팅을 도입한다. 본 연구는 테스트 데이터 생성 과정이 테스트 대상 프로그램의 구현에 대한 지식을 필요로하지 않는다는 점에서 다른 방법들과 다르다. 또한, 제안된 방법의 효율성을 보이기 위하여 몇 가지 실험을 통해서 블랙박스 테스트 생성 기법은 랜덤 테스팅과 비교한다.

  • PDF

유전성 암과 유전상담 (Hereditary cancer and genetic counseling)

  • 정승용
    • Journal of Genetic Medicine
    • /
    • 제4권1호
    • /
    • pp.15-21
    • /
    • 2007
  • Hereditary syndromes cause approximately 5 to 10% of overall cancer cases. Cancer related with genetic syndromes are found elsewhere, including stomach, breast, colorectum, ovary, brain and so on. Because hereditary cancers are due to germline mutations, these patients have unique clinical features distinct from sporadic cancer. Generally these features include (i) early age-of onset of cancer, (ii) frequent association with synchronous or metachronous tumors, (iii) frequent bilateral involvement in paired organs (iv) frequent association with other site tumors or characteristic clinical manifestation specific to each genetic syndrome. Due to these differences, the management strategy for patients with hereditary cancer is quite different from that for sporadic cancer. Additionally, there are important screening and surveillance implications for family members. Genetic counselling is prerequisite to these families for risk assessment by pedigree analysis, and guidance to clinical or genetic testing. The genes responsible for these syndromes has recently identified, as a result, genetic testing has become important determining factor in clinical decisions.

  • PDF